Pyxis Tankers PXS 深 滬
已收盤 12-12 16:00:00 美东时间
2.94
-0.075
-2.49%
華盛通- 最 高3.00
- 今 開2.98
- 成交量 1.26万股
- 最 低 2.94
- 昨 收 3.015
- 總市值 3082.85万
- 52周最高 4.40
- 市盈率 靜 3.22
- 換手率 0.12%
- 52周最低 2.47
- 委 比 -71.43%
- 總股本 1048.59万
- 歷史最高 48.88
- 量 比 0.73
- 振 幅 1.99%
- 歷史最低 1.416
- 每 手 1
- 風險率 0.39%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Pyxis Tankers Unveils Q3 Results and $3 Million Share Buyback
Pyxis Tankers ( ($PXS) ) has provided an announcement. On November 19, 2025, Py...
11-26 21:29
Pyxis Tankers announces $3M buyback program
Pyxis Tankers (NASDAQ:PXS) announced on Friday that its Board of Directors authorized the repurchase of up to $3M of our common shares on November 19, 2025. Pursuant to the authorization, purchases ma...
11-21 22:13
Pyxis Tankers Q3 EPS $0.11 Misses $0.17 Estimate, Sales $9.700M Miss $11.350M Estimate
Pyxis Tankers (NASDAQ:PXS) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.17 by 35.29 percent. This is a 64.52 percent decrease over earnings of $0.31 per share from the
11-21 05:07
Earnings Scheduled For November 20, 2025
Companies Reporting Before The Bell • Atkore (NYSE:ATKR) is likely to report qu...
11-20 19:11
Pyxis Tankers Announces Date for the Release of the Third Quarter 2025 Results
Pyxis Tankers Inc. announced it will release its unaudited third-quarter 2025 financial results after market close on November 20. A presentation of the results will be available on its website. The company operates a modern fleet of six mid-sized eco-vessels, including MR product tankers, a Kamsarmax bulk carrier, and interests in two dry-bulk ventures. With strong capital resources and an experienced team, Pyxis is well-positioned for fleet exp...
11-19 21:05
Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets
Pyxis Oncology has appointed Alex Kane as Senior Vice President of Investor Relations & Capital Markets, bringing 20 years of experience in life sciences and capital markets. Kane previously worked at Guggenheim Securities and has managed IPOs and investor relations for biotech companies. His expertise in investor communication and capital markets is expected to support Pyxis Oncology's clinical advancements and milestones.
10-09 11:30
Pyxis Tankers Appoints Deloitte as New Auditor
Pyxis Tankers ( ($PXS) ) just unveiled an announcement. On October 1, 2025, Pyx...
10-06 20:28
Plus Therapeutics Announces Successful Accreditation and Certification for Its CNSide® Diagnostics Clinical Laboratory
CNSide Diagnostics, a subsidiary of Plus Therapeutics, Inc., has received a CLIA certification from the Centers for Medicare & Medicaid Services (CMS) for its Houston-based lab. This certification is a crucial step toward broad U.S. market release of the CNSide CSF Assay Platform, meeting federal and state regulatory requirements. It enables the company to pursue state licensure, secure insurance coverage, and expand payment coding, supporting th...
09-18 11:30
Pyxis Tankers Q2 EPS $(0.19) Down From $0.43 YoY, Sales $9.15M Miss $9.94M Estimate
Pyxis Tankers (NASDAQ:PXS) reported quarterly losses of $(0.19) per share. This is a 144.19 percent decrease over earnings of $0.43 per share from the same period last year. The company reported quarterly sales of $9.15
08-08 20:02
Earnings Scheduled For August 8, 2025
Companies Reporting Before The Bell • BeOne Medicines (NASDAQ:ONC) is expected ...
08-08 16:32
